Literature DB >> 18789990

CD8+ regulatory T cells in persistent human viral infections.

Eva Billerbeck1, Robert Thimme.   

Abstract

Regulatory T cells (T(reg) cells) play an important role in the regulation and suppression of immune responses to self- and foreign antigens. Suppressed and impaired host immune responses are a major characteristic of many persistent human virus infections, such as those caused by human immunodeficiency virus (HIV), hepatitis C virus (HCV), and herpes virus. It has recently become evident that immune regulation mediated by T(reg) cells may comprise one mechanism that contributes to the impairment of virus-specific immune responses. Indeed, during viral infection, the generation of distinct subsets of CD4+ as well as CD8+ T(reg) cells has been reported. The phenotypic and functional heterogeneity of T(reg) cell subsets involved in the suppression of virus-specific immune responses suggests that different mechanisms and factors contribute to the generation of those cells during viral infection. This review focuses on the CD8+ T(reg) cell subset and summarizes current knowledge about the induction and function of CD8+ T(reg) cells in persistent human virus infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789990     DOI: 10.1016/j.humimm.2008.07.016

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  14 in total

1.  Acquisition of regulatory function by human CD8(+) T cells treated with anti-CD3 antibody requires TNF.

Authors:  Vitaly Ablamunits; Brygida Bisikirska; Kevan C Herold
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

Review 2.  CD8(+) Tregs in autoimmunity: learning "self"-control from experience.

Authors:  Sue Tsai; Xavier Clemente-Casares; Pere Santamaria
Journal:  Cell Mol Life Sci       Date:  2011-06-14       Impact factor: 9.261

Review 3.  CD8+ Tregs in lupus, autoimmunity, and beyond.

Authors:  Ravi K Dinesh; Brian J Skaggs; Antonio La Cava; Bevra H Hahn; Ram Pyare Singh
Journal:  Autoimmun Rev       Date:  2010-04-10       Impact factor: 9.754

4.  NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibody.

Authors:  Vitaly Ablamunits; Octavian Henegariu; Paula Preston-Hurlburt; Kevan C Herold
Journal:  Eur J Immunol       Date:  2011-06-06       Impact factor: 5.532

5.  Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates.

Authors:  Davide Simone; Frank Penkava; Anna Ridley; Stephen Sansom; M Hussein Al-Mossawi; Paul Bowness
Journal:  Commun Biol       Date:  2021-12-14

6.  FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity.

Authors:  Melinda S Suchard; Elizabeth Mayne; Victoria A Green; Sharon Shalekoff; Samantha L Donninger; Wendy S Stevens; Clive M Gray; Caroline T Tiemessen
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

7.  Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection.

Authors:  Fang Wang; Jing Chi; Guangyong Peng; Feng Zhou; Jinfeng Wang; Lingyun Li; Dongju Feng; Fangyi Xie; Bin Gu; Jian Qin; Yun Chen; Kun Yao
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

8.  Regulatory CD8+ T cells associated with erosion of immune surveillance in persistent virus infection suppress in vitro and have a reversible proliferative defect.

Authors:  Zhuting Hu; Weijun Zhang; Edward J Usherwood
Journal:  J Immunol       Date:  2013-06-03       Impact factor: 5.422

9.  Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbits.

Authors:  Jiafen Hu; Lynn R Budgeon; Karla K Balogh; Xuwen Peng; Nancy M Cladel; Neil D Christensen
Journal:  Trials Vaccinol       Date:  2014

Review 10.  Coinfection with HIV-1 and HCV--a one-two punch.

Authors:  Arthur Y Kim; Raymond T Chung
Journal:  Gastroenterology       Date:  2009-06-21       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.